Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000631198 | SCV000752211 | uncertain significance | Ornithine aminotransferase deficiency | 2022-04-23 | criteria provided, single submitter | clinical testing | This sequence change replaces glycine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 17 of the OAT protein (p.Gly17Arg). This variant is present in population databases (rs760716065, gnomAD 0.0009%). This variant has not been reported in the literature in individuals affected with OAT-related conditions. ClinVar contains an entry for this variant (Variation ID: 526625). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0"). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Natera, |
RCV000631198 | SCV002086930 | uncertain significance | Ornithine aminotransferase deficiency | 2020-11-23 | no assertion criteria provided | clinical testing | |
Institute of Human Genetics, |
RCV004817832 | SCV005073226 | uncertain significance | Retinal dystrophy | 2023-01-01 | no assertion criteria provided | clinical testing |